Drug Profile
Research programme: wound healing therapeutics - Compass Biomedical
Latest Information Update: 27 Dec 2016
Price :
$50
*
At a glance
- Originator Arteriocyte
- Class Stem cell therapies
- Mechanism of Action Angiogenesis inducing agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Wounds
Most Recent Events
- 12 Dec 2016 Arteriocyte is now called Compass Biomedical
- 21 Jan 2011 Discontinued for Wounds in USA (unspecified route)